Covid-19 vaccine: Serum Institute of India to start human trials from next month2 min read 19 Jul 2020, 10:22 PM IST
Serum Institute has entered a manufacturing partnership with AstraZeneca to produce and supply 1 billion doses of the Covid-19 vaccine being developed by Oxford University, said CEO Adar Poonawalla
At least seven Indian pharma companies are working to develop a vaccine against coronavirus
Leading vaccine major Serum Institute of India on Sunday said that it is hoping to develop a Covid-19 vaccine by the year-end and also said that it will be starting human trials of its AstraZeneca Oxford vaccine from August.
Select your Category